SLXN
NASDAQ · Biotechnology
Silexion Therapeutics Corp
$0.42
-0.04 (-8.65%)
Open$0.41
Previous Close$0.46
Day High$0.42
Day Low$0.37
52W High$89.80
52W Low$1.50
Volume—
Avg Volume202.4K
Market Cap1.99M
P/E Ratio—
EPS$-55.60
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+8,524.5% upside
Current
$0.42
$0.42
Target
$36.24
$36.24
$26.81
$36.24 avg
$52.45
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.24M | 2.11M | 2.20M |
| Net Income | -331,103 | -245,653 | -236,110 |
| Profit Margin | -14.8% | -11.6% | -10.7% |
| EBITDA | -455,957 | -486,512 | -478,296 |
| Free Cash Flow | -187,144 | -193,211 | -204,399 |
| Rev Growth | -3.1% | +9.8% | -1.4% |
| Debt/Equity | 0.51 | 0.41 | 0.44 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 35.2 | 28.41B |